Annual EPS
-$1.64
+$1.27+43.64%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual earnings per share is -$1.64, with the most recent change of +$1.27 (+43.64%) on December 31, 2023.
- During the last 3 years, FATE annual EPS has risen by +$0.46 (+21.90%).
- FATE annual EPS is now -60.78% below its all-time high of -$1.02, reached on December 31, 2017.
Performance
FATE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.40
-$0.07-21.21%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly earnings per share is -$0.40, with the most recent change of -$0.07 (-21.21%) on September 30, 2024.
- Over the past year, FATE quarterly EPS has increased by +$0.06 (+13.04%).
- FATE quarterly EPS is now -110.53% below its all-time high of -$0.19, reached on March 31, 2023.
Performance
FATE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.65
+$0.06+3.51%
September 30, 2024
Summary
- As of February 7, 2025, FATE TTM earnings per share is -$1.65, with the most recent change of +$0.06 (+3.51%) on September 30, 2024.
- Over the past year, FATE TTM EPS has increased by +$0.12 (+6.78%).
- FATE TTM EPS is now -255.68% below its all-time high of -$0.46, reached on September 30, 2012.
Performance
FATE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
FATE EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.6% | +13.0% | +6.8% |
| 3 y3 years | +21.9% | -110.5% | +31.8% |
| 5 y5 years | -37.8% | +9.1% | -5.1% |
FATE EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +43.6% | -110.5% | +53.5% | -0.6% | +45.9% |
| 5 y | 5-year | -13.9% | +43.6% | -110.5% | +53.5% | -15.4% | +45.9% |
| alltime | all time | -60.8% | +53.7% | -110.5% | +53.5% | -255.7% | +45.9% |
Fate Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.40(+21.2%) | -$1.65(-3.5%) |
| Jun 2024 | - | -$0.33(-29.8%) | -$1.71(-10.9%) |
| Mar 2024 | - | -$0.47(+4.4%) | -$1.92(+17.1%) |
| Dec 2023 | -$1.64(-43.6%) | -$0.45(-2.2%) | -$1.64(-7.3%) |
| Sep 2023 | - | -$0.46(-14.8%) | -$1.77(-18.4%) |
| Jun 2023 | - | -$0.54(+184.2%) | -$2.17(-10.3%) |
| Mar 2023 | - | -$0.19(-67.2%) | -$2.42(-16.8%) |
| Dec 2022 | -$2.91(+29.9%) | -$0.58(-32.6%) | -$2.91(-4.6%) |
| Sep 2022 | - | -$0.86(+8.9%) | -$3.05(+15.5%) |
| Jun 2022 | - | -$0.79(+16.2%) | -$2.64(+8.6%) |
| Mar 2022 | - | -$0.68(-5.6%) | -$2.43(+9.0%) |
| Dec 2021 | -$2.24(+6.7%) | -$0.72(+60.0%) | -$2.23(+5.2%) |
| Sep 2021 | - | -$0.45(-22.4%) | -$2.12(-9.8%) |
| Jun 2021 | - | -$0.58(+20.8%) | -$2.35(+10.8%) |
| Mar 2021 | - | -$0.48(-21.3%) | -$2.12(+1.9%) |
| Dec 2020 | -$2.10(+45.8%) | -$0.61(-10.3%) | -$2.08(+13.0%) |
| Sep 2020 | - | -$0.68(+94.3%) | -$1.84(+17.9%) |
| Jun 2020 | - | -$0.35(-20.5%) | -$1.56(-0.6%) |
| Mar 2020 | - | -$0.44(+18.9%) | -$1.57(+9.8%) |
| Dec 2019 | -$1.44(+21.0%) | -$0.37(-7.5%) | -$1.43(+9.2%) |
| Sep 2019 | - | -$0.40(+11.1%) | -$1.31(+7.4%) |
| Jun 2019 | - | -$0.36(+20.0%) | -$1.22(-0.8%) |
| Mar 2019 | - | -$0.30(+20.0%) | -$1.23(+2.5%) |
| Dec 2018 | -$1.19 | -$0.25(-19.4%) | -$1.20(-3.2%) |
| Sep 2018 | - | -$0.31(-16.2%) | -$1.24(+4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$0.37(+37.0%) | -$1.19(+13.3%) |
| Mar 2018 | - | -$0.27(-6.9%) | -$1.05(+2.9%) |
| Dec 2017 | -$1.02(-2.9%) | -$0.29(+11.5%) | -$1.02(+8.5%) |
| Sep 2017 | - | -$0.26(+13.0%) | -$0.94(-1.1%) |
| Jun 2017 | - | -$0.23(-4.2%) | -$0.95(-5.9%) |
| Mar 2017 | - | -$0.24(+14.3%) | -$1.01(-4.7%) |
| Dec 2016 | -$1.05(-11.0%) | -$0.21(-22.2%) | -$1.06(-4.5%) |
| Sep 2016 | - | -$0.27(-6.9%) | -$1.11(+2.8%) |
| Jun 2016 | - | -$0.29(0.0%) | -$1.08(-3.6%) |
| Mar 2016 | - | -$0.29(+11.5%) | -$1.12(-7.4%) |
| Dec 2015 | -$1.18(-7.1%) | -$0.26(+8.3%) | -$1.21(-3.2%) |
| Sep 2015 | - | -$0.24(-27.3%) | -$1.25(-6.0%) |
| Jun 2015 | - | -$0.33(-13.2%) | -$1.33(+2.3%) |
| Mar 2015 | - | -$0.38(+26.7%) | -$1.30(+3.2%) |
| Dec 2014 | -$1.27(-64.1%) | -$0.30(-6.3%) | -$1.26(+1.5%) |
| Sep 2014 | - | -$0.32(+6.7%) | -$1.24(+0.2%) |
| Jun 2014 | - | -$0.30(-11.8%) | -$1.24(+0.9%) |
| Mar 2014 | - | -$0.34(+21.0%) | -$1.23(-4.7%) |
| Dec 2013 | -$3.54(+120.5%) | -$0.28(-11.4%) | -$1.29(-12.7%) |
| Sep 2013 | - | -$0.32(+9.7%) | -$1.47(-9.1%) |
| Jun 2013 | - | -$0.29(-27.8%) | -$1.62(+21.7%) |
| Mar 2013 | - | -$0.40(-14.6%) | -$1.33(+42.9%) |
| Dec 2012 | -$1.61(+6.0%) | -$0.47(+1.0%) | -$0.93(+101.0%) |
| Sep 2012 | - | -$0.46 | -$0.46 |
| Dec 2011 | -$1.51 | - | - |
FAQ
- What is Fate Therapeutics annual earnings per share?
- What is the all time high annual EPS for Fate Therapeutics?
- What is Fate Therapeutics annual EPS year-on-year change?
- What is Fate Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Fate Therapeutics?
- What is Fate Therapeutics quarterly EPS year-on-year change?
- What is Fate Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Fate Therapeutics?
- What is Fate Therapeutics TTM EPS year-on-year change?
What is Fate Therapeutics annual earnings per share?
The current annual EPS of FATE is -$1.64
What is the all time high annual EPS for Fate Therapeutics?
Fate Therapeutics all-time high annual earnings per share is -$1.02
What is Fate Therapeutics annual EPS year-on-year change?
Over the past year, FATE annual earnings per share has changed by +$1.27 (+43.64%)
What is Fate Therapeutics quarterly earnings per share?
The current quarterly EPS of FATE is -$0.40
What is the all time high quarterly EPS for Fate Therapeutics?
Fate Therapeutics all-time high quarterly earnings per share is -$0.19
What is Fate Therapeutics quarterly EPS year-on-year change?
Over the past year, FATE quarterly earnings per share has changed by +$0.06 (+13.04%)
What is Fate Therapeutics TTM earnings per share?
The current TTM EPS of FATE is -$1.65
What is the all time high TTM EPS for Fate Therapeutics?
Fate Therapeutics all-time high TTM earnings per share is -$0.46
What is Fate Therapeutics TTM EPS year-on-year change?
Over the past year, FATE TTM earnings per share has changed by +$0.12 (+6.78%)